Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Syndromes, Hereditary

Explore clinical trials studying Neoplastic Syndromes, Hereditary. Study availability and eligibility vary by location and protocol.

876 public trials 156 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Syndromes, Hereditary trial results

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 29 locations
View Trial Details
Recruiting

Li-Fraumeni Syndrome/TP53 Biobank

NCT04367246

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +6 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Children's Hospital of Philadelphia Phildelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

NCT05849662

Conditions
Bone Marrow Diseases, CBL Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital of Colorado Denver, Colorado, United States
View all 21 locations
View Trial Details
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University School of Medicine Indianopolis, Indiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details

Related conditions